Genomics Advocate von Eschenbach Confirmed as FDA Commissioner | GenomeWeb
NEW YORK (GenomeWeb News) — The US Senate yesterday confirmed Andrew von Eschenbach to be the new commissioner off the Food and Drug Administration.
 
The Bush appointee, a staunch supporter of genomic technologies in drug discovery, was approved after serving as acting commissioner since September 2005 after former commissioner Lester Crawford resigned.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.